geographic atrophy Archives - Insight

Novartis targets GA gene therapy in Gyroscope Therapeutics deal

Myles Hume — Thu, 06 Jan 2022 02:01:51 +0000

Novartis will make an upfront payment of AU$1.1 billion for the gene therapy, with more payments to follow.

Novartis has announced it is acquiring Gyroscope Therapeutics, the UK-based company behind an investigational dry ADM gene therapy that is the focus of key clinical trials in Australia. The deal, which
Read More

The post Novartis targets GA gene therapy in Gyroscope Therapeutics deal appeared first on Insight.

Prof Robyn Guymer ‘thrilled’ by Phase 3 results of pegcetacoplan for dry AMD

Myles Hume — Fri, 17 Sep 2021 03:00:51 +0000

Prof Robyn Guymer was the principal investigator at CERA, which recruited four patients into the DERBY study.

Prominent Melbourne retinal disease researcher Professor Robyn Guymer is encouraged by the Phase 3 results of a trial she’s been involved in, investigating a new therapy she says is the only intervention
Read More

The post Prof Robyn Guymer ‘thrilled’ by Phase 3 results of pegcetacoplan for dry AMD appeared first on Insight.